Jeanette Dawa1, Sandra S Chaves2, Antoinette Ba Nguz3, Rosalia Kalani4, Edwina Anyango5, Dominic Mutie5, Phillip Muthoka5, Collins Tabu5, Marybeth Maritim6, Evans Amukoye6, Fred Were6. 1. Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative, Agency for Preventive Medicine (AMP), Paris, France. Electronic address: jdawa@wsuglobalhealth.org. 2. Centers for Disease Control and Prevention, Nairobi, Kenya; Influenza Division, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: bev8@cdc.gov. 3. Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative, Agency for Preventive Medicine (AMP), Paris, France. 4. Disease Surveillance and Response Unit, Ministry of Health, Kenya; Kenya National Immunization Technical Advisory Group (KENITAG), Nairobi, Kenya. 5. Kenya National Immunization Technical Advisory Group (KENITAG), Nairobi, Kenya; National Vaccines Immunization Programme, Ministry of Health, Kenya. 6. Kenya National Immunization Technical Advisory Group (KENITAG), Nairobi, Kenya.
Abstract
BACKGROUND: In 2014 the Kenya National Immunization Technical Advisory Group (KENITAG) was asked by the Ministry of Health to provide an evidence-based recommendation on whether the seasonal influenza vaccine should be introduced into the national immunization program (NIP). METHODS: We reviewed KENITAG manuals, reports and meeting minutes generated between June 2014 and June 2016 in order to describe the process KENITAG used in arriving at that recommendation and the challenges encountered. RESULTS: KENITAG developed a recommendation framework to identify critical, important and non-critical data elements that would guide deliberations on the subject. Literature searches were conducted in several databases and the quality of scientific articles obtained was assessed using the Critical Appraisal Skills Programme tool. There were significant gaps in knowledge on the national burden of influenza disease among key risk groups, i.e., pregnant women, individuals with co-morbidities, the elderly and health care workers. Insufficient funding and limited work force hindered KENITAG activities. In 2016 KENITAG recommended introduction of the annual seasonal influenza vaccine among children 6 to 23 months of age. However, the recommendation was contingent on implementation of a pilot study to address gaps in local data on the socio-economic impact of influenza vaccination programs, strategies for vaccine delivery, and the impact of the vaccination program on the healthcare workforce and existing immunization program. KENITAG did not recommend the influenza vaccine for any other risk group due to lack of local burden of disease data. CONCLUSION: Local data are a critical element in NITAG deliberations, however, where local data and in particular burden of disease data are lacking, there is need to adopt scientifically acceptable methods of utilizing findings from other countries to inform local decisions in a manner that is valid and acceptable to decision makers.
BACKGROUND: In 2014 the Kenya National Immunization Technical Advisory Group (KENITAG) was asked by the Ministry of Health to provide an evidence-based recommendation on whether the seasonal influenza vaccine should be introduced into the national immunization program (NIP). METHODS: We reviewed KENITAG manuals, reports and meeting minutes generated between June 2014 and June 2016 in order to describe the process KENITAG used in arriving at that recommendation and the challenges encountered. RESULTS: KENITAG developed a recommendation framework to identify critical, important and non-critical data elements that would guide deliberations on the subject. Literature searches were conducted in several databases and the quality of scientific articles obtained was assessed using the Critical Appraisal Skills Programme tool. There were significant gaps in knowledge on the national burden of influenza disease among key risk groups, i.e., pregnant women, individuals with co-morbidities, the elderly and health care workers. Insufficient funding and limited work force hindered KENITAG activities. In 2016 KENITAG recommended introduction of the annual seasonal influenza vaccine among children 6 to 23 months of age. However, the recommendation was contingent on implementation of a pilot study to address gaps in local data on the socio-economic impact of influenza vaccination programs, strategies for vaccine delivery, and the impact of the vaccination program on the healthcare workforce and existing immunization program. KENITAG did not recommend the influenza vaccine for any other risk group due to lack of local burden of disease data. CONCLUSION: Local data are a critical element in NITAG deliberations, however, where local data and in particular burden of disease data are lacking, there is need to adopt scientifically acceptable methods of utilizing findings from other countries to inform local decisions in a manner that is valid and acceptable to decision makers.
Authors: Henry N Njuguna; Sherif R Zaki; Drucilla J Roberts; Emily A Rogena; Edwin Walong; Corinne L Fligner; M Kelly Keating; Andrew K Gachii; Elizabeth Maleche-Obimbo; Grace Irimu; John Mathaiya; Noelle Orata; Rosemarie Lopokoiyit; Jackson Michuki; Gideon O Emukule; Clayton O Onyango; Stella Gikunju; Collins Owuor; Peter K Muturi; Milka Bunei; Maria Gloria Carvalho; Barry Fields; Joshua A Mott; Marc-Alain Widdowson; Sandra S Chaves Journal: Pediatr Infect Dis J Date: 2021-08-01 Impact factor: 3.806
Authors: Joseph S Bresee; Kathryn E Lafond; Margaret McCarron; Eduardo Azziz-Baumgartner; Susan Y Chu; Malembe Ebama; Alan R Hinman; Anonh Xeuatvongsa; Silvia Bino; Dominique Richardson; Rachael M Porter; Ann Moen; Mark McKinlay Journal: Vaccine Date: 2019-07-06 Impact factor: 3.641
Authors: Festus M Nyasimi; David Collins Owuor; Joyce M Ngoi; Alexander G Mwihuri; Grieven P Otieno; James R Otieno; George Githinji; Joyce U Nyiro; David James Nokes; Charles N Agoti Journal: Virus Evol Date: 2020-08-16
Authors: D Collins Owuor; Joyce M Ngoi; James R Otieno; Grieven P Otieno; Festus M Nyasimi; Joyce U Nyiro; Charles N Agoti; Sandra S Chaves; D James Nokes Journal: Influenza Other Respir Viruses Date: 2020-01-13 Impact factor: 5.606
Authors: Jeanette Dawa; Gideon O Emukule; Edwine Barasa; Marc Alain Widdowson; Omu Anzala; Edwin van Leeuwen; Marc Baguelin; Sandra S Chaves; Rosalind M Eggo Journal: BMC Med Date: 2020-08-20 Impact factor: 8.775